Skip to main content
. 2008 Apr;152(1):57–63. doi: 10.1111/j.1365-2249.2008.03592.x

Fig. 2.

Fig. 2

Serum levels of neutrophil gelatinase-associated lipocalin (NGAL) in virological responders (n = 26) and non-responders (n = 11) before (baseline) and at different time-points after initiating highly active anti-retroviral therapy (HAART). Data are mean ± standard deviation. The Wilcoxon-signed rank test was used for comparison of paired data during HAART. *P < 0·05 versus baseline levels.